Advertisement
Research Article| Volume 69, ISSUE 1, P51-59, July 2018

Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice

  • Author Footnotes
    † These authors contribute equally to this work.
    Shenhai Gong
    Footnotes
    † These authors contribute equally to this work.
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Author Footnotes
    † These authors contribute equally to this work.
    Tian Lan
    Footnotes
    † These authors contribute equally to this work.
    Affiliations
    Guangdong Pharmaceutical University, Guangzhou, China
    Search for articles by this author
  • Liyan Zeng
    Affiliations
    School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Haihua Luo
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Xiaoyu Yang
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Na Li
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Xiaojiao Chen
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Zhanguo Liu
    Affiliations
    Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Rui Li
    Affiliations
    Guangdong Pharmaceutical University, Guangzhou, China
    Search for articles by this author
  • Sanda Win
    Affiliations
    University of Southern California Research Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, USA
    Search for articles by this author
  • Shuwen Liu
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Hongwei Zhou
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Bernd Schnabl
    Affiliations
    Department of Medicine, University of California San Diego, La Jolla, USA
    Search for articles by this author
  • Author Footnotes
    ‡ These authors share co-senior author.
    Yong Jiang
    Correspondence
    Corresponding authors. Addresses: Department of Pathophysiology, Southern Medical University, Guangzhou, China. Tel.: +86 (20)61648231 (Y. Jiang), or Department of Pathophysiology, Southern Medical University, Guangzhou, China. Tel.: +86 (20)61648172 839 (P. Chen).
    Footnotes
    ‡ These authors share co-senior author.
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Author Footnotes
    ‡ These authors share co-senior author.
    Neil Kaplowitz
    Footnotes
    ‡ These authors share co-senior author.
    Affiliations
    University of Southern California Research Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, USA
    Search for articles by this author
  • Author Footnotes
    ‡ These authors share co-senior author.
    Peng Chen
    Correspondence
    Corresponding authors. Addresses: Department of Pathophysiology, Southern Medical University, Guangzhou, China. Tel.: +86 (20)61648231 (Y. Jiang), or Department of Pathophysiology, Southern Medical University, Guangzhou, China. Tel.: +86 (20)61648172 839 (P. Chen).
    Footnotes
    ‡ These authors share co-senior author.
    Affiliations
    State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China

    Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China

    Department of Pathophysiology, Southern Medical University, Guangzhou, China

    Department of Intensive Care Unit, Zhujiang Hospital, Southern Medical University, Guangzhou, China
    Search for articles by this author
  • Author Footnotes
    † These authors contribute equally to this work.
    ‡ These authors share co-senior author.
Published:March 07, 2018DOI:https://doi.org/10.1016/j.jhep.2018.02.024

      Highlights

      • The diurnal variation of acetaminophen induced acute liver injury is dependent on gut microbiota.
      • Gut microbiota derived PPD played the key role in the diurnal variation of acetaminophen induced hepatotoxicity.
      • PPD participated in liver damage development by directly depleting hepatic glutathione levels.

      Background & Aims

      Acetaminophen (APAP) induced hepatotoxicity is a leading cause of acute liver failure worldwide. It is well established that the liver damage induced by acetaminophen exhibits diurnal variation. However, the detailed mechanism for the hepatotoxic variation is not clear. Herein, we aimed to determine the relative contributions of gut microbiota in modulating the diurnal variation of hepatotoxicity induced by APAP.

      Methods

      Male Balb/C mice were treated with or without antibiotics and a single dose of orally administered APAP (300 mg/kg) at ZT0 (when the light is on-start of resting period) and ZT12 (when the light is off-start of active period).

      Results

      In agreement with previous findings, hepatic injury was markedly enhanced at ZT12 compared with ZT0. Interestingly, upon antibiotic treatment, ZT12 displayed a protective effect against APAP hepatotoxicity similar to ZT0. Moreover, mice that received the cecal content from ZT12 showed more severe liver damage than mice that received the cecal content from ZT0. 16S sequencing data revealed significant differences in the cecal content between ZT0 and ZT12 in the compositional level. Furthermore, metabolomic analysis showed that the gut microbial metabolites were also different between ZT0 and ZT12. Specifically, the level of 1-phenyl-1,2-propanedione (PPD) was significantly higher at ZT12 than ZT0. Treatment with PPD alone did not cause obvious liver damage. However, PPD synergistically enhanced APAP-induced hepatic injury in vivo and in vitro. Finally, we found Saccharomyces cerevisiae, which could reduce intestinal PPD levels, was able to markedly alleviate APAP-induced liver damage at ZT12.

      Conclusions

      The gut microbial metabolite PPD was responsible, at least in part, for the diurnal variation of hepatotoxicity induced by APAP by decreasing glutathione levels.

      Lay summary

      Acetaminophen (APAP) induced acute liver failure because of over dose is a leading public health problem. APAP-induced liver injury exhibits diurnal variation, specifically APAP causes more severe liver damage when taken at night compared with in the morning. Herein, we showed that gut microbial metabolite, 1-phenyl-1,2-propanedione is involved in the rhythmic hepatotoxicity induced by APAP, by depleting hepatic glutathione (an important antioxidant) levels. Our data suggest gut microbiota may be a potential target for reducing APAP-induced acute liver injury.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      Author names in bold designate shared co-first authorship

        • Sheehan W.J.
        • Mauger D.T.
        • Paul I.M.
        • Moy J.N.
        • Boehmer S.J.
        • Szefler S.J.
        • et al.
        Acetaminophen vs. ibuprofen in young children with mild persistent asthma.
        N Engl J Med. 2016; 375: 619-630
        • Lu Y.
        • Zhang C.
        • Chen Y.H.
        • Wang H.
        • Zhang Z.H.
        • Chen X.
        • et al.
        Immature mice are more susceptible than adult mice to acetaminophen-induced acute liver injury.
        Sci Rep. 2017; 7: 42736
        • Larsen F.S.
        • Wendon J.
        Understanding paracetamol-induced liver failure.
        Intensive Care Med. 2014; 40: 888-890
        • Larson A.M.
        • Polson J.
        • Fontana R.J.
        • Davern T.J.
        • Lalani E.
        • Hynan L.S.
        • et al.
        Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.
        Hepatology. 2005; 42: 1364-1372
        • Schäfer C.
        • Schröder K.R.
        • Höglinger O.
        • Tollabimazraehno S.
        • Lornejad-Schäfer M.R.
        Acetaminophen changes intestinal epithelial cell membrane properties, subsequently affecting absorption processes.
        Cell Physiol Biochem. 2013; 32: 431-447
        • Possamai L.A.
        • McPhail M.J.
        • Khamri W.
        • Wu B.
        • Concas D.
        • Harrison M.
        • et al.
        The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity.
        Liver Int. 2015; 35: 764-773
        • Kučera O.
        • Endlicher R.
        • Rychtrmoc D.
        • Lotková H.
        • Sobotka O.
        • Červinková Z.
        Acetaminophen toxicity in rat and mouse hepatocytes in vitro.
        Drug Chem Toxicol. 2017; 40: 448-456
        • Du K.
        • Williams C.D.
        • McGill M.R.
        • Jaeschke H.
        Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.
        Toxicol Appl Pharmacol. 2014; 281: 58-66
        • van Rongen A.
        • Välitalo P.A.
        • Peeters M.Y.
        • Boerma D.
        • Huisman F.W.
        • van Ramshorst B.
        • et al.
        Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen.
        Clin Pharmacokinet. 2016; 55: 833-847
        • Kaplowitz N.
        • Win S.
        • Than T.A.
        • Liu Z.X.
        • Dara L.
        Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity.
        J Hepatol. 2015; 63: 5-7
        • Zhang J.
        • Min R.W.M.
        • Le K.
        • Zhou S.
        • Aghajan M.
        • Than T.A.
        • et al.
        The role of MAP2 kinases and p38 kinase in acute murine liver injury models.
        Cell Death Dis. 2017; 8: e2903
        • Kim Y.H.
        • Hwang J.H.
        • Kim K.S.
        • Noh J.R.
        • Choi D.H.
        • Kim D.K.
        • et al.
        Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice.
        J Hepatol. 2015; 63: 75-82
        • Gunawan B.K.
        • Liu Z.X.
        • Han D.
        • Hanawa N.
        • Gaarde W.A.
        • Kaplowitz N.
        C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.
        Gastroenterology. 2006; 131: 165-178
        • Kakan X.
        • Chen P.
        • Zhang J.
        Clock gene mPer2 functions in diurnal variation of acetaminophen induced hepatotoxicity in mice.
        Exp Toxicol Pathol. 2011; 63: 581-585
        • Kim Y.C.
        • Lee S.J.
        Temporal variation in hepatotoxicity and metabolism of acetaminophen in mice.
        Toxicology. 1998; 128: 53-61
        • Thaiss C.A.
        • Zeevi D.
        • Levy M.
        • Zilberman-Schapira G.
        • Suez J.
        • Tengeler A.C.
        • et al.
        Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.
        Cell. 2014; 159: 514-529
        • Fouts D.E.
        • Torralba M.
        • Nelson K.E.
        • Brenner D.A.
        • Schnabl B.
        Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.
        J Hepatol. 2012; 56: 1283-1292
        • Chen P.
        • Torralba M.
        • Tan J.
        • Embree M.
        • Zengler K.
        • Stärkel P.
        • et al.
        Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.
        Gastroenterology. 2015; 148: 203-214
        • Walker A.
        • Pfitzner B.
        • Neschen S.
        • Kahle M.
        • Harir M.
        • Lucio M.
        • et al.
        Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet.
        ISME J. 2014; 8: 2380-2396
        • Han H.
        • Xiao H.
        • Zhang K.
        • Lu Z.
        Impact of 4-epi-oxytetracycline on the gut microbiota and blood metabolomics of Wistar rats.
        Sci Rep. 2016; 6: 23141
        • Gregory J.C.
        • Buffa J.A.
        • Org E.
        • Wang Z.
        • Levison B.S.
        • Zhu W.
        • et al.
        Transmission of atherosclerosis susceptibility with gut microbial transplantation.
        J Biol Chem. 2015; 290: 5647-5660
        • Schuijt T.J.
        • Lankelma J.M.
        • Scicluna B.P.
        • de Sousa e Melo F.
        • Roelofs J.J.
        • de Boer J.D.
        • et al.
        The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.
        Gut. 2016; 65: 575-583
        • Wagnerberger S.
        • Spruss A.
        • Kanuri G.
        • Stahl C.
        • Schröder M.
        • Vetter W.
        • et al.
        Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.
        J Nutr Biochem. 2013; 24: 531-538
        • Hooper L.V.
        • Wong M.H.
        • Thelin A.
        • Hansson L.
        • Falk P.G.
        • Gordon J.I.
        Molecular analysis of commensal host–microbial relationships in the intestine.
        Science. 2001; 291: 881-884
        • Yip L.Y.
        • Aw C.C.
        • Lee S.H.
        • Hong Y.S.
        • Ku H.C.
        • Xu W.H.
        • et al.
        The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat.
        Hepatology. 2018; ([In Press])https://doi.org/10.1002/hep.29327
        • Lourenço E.
        • Rodrigues J.A.R.
        • Moran P.J.S.
        Preparation of an (−)-ephedrine intermediate through asymmetric reduction of 1-phenyl-1,2-propanedione by anaerobically pre-treated baker’s yeast.
        J Mol Catal B-Enzym. 2004; 29: 37-40
        • Leone V.
        • Gibbons S.M.
        • Martinez K.
        • Hutchison A.L.
        • Huang E.Y.
        • Cham C.M.
        • et al.
        Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism.
        Cell Host Microbe. 2015; 17: 681-689
        • Koeth R.A.
        • Wang Z.
        • Levison B.S.
        • Buffa J.A.
        • Org E.
        • Sheehy B.T.
        • et al.
        Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
        Nat Med. 2013; 19: 576-585
        • Chen M.L.
        • Yi L.
        • Zhang Y.
        • Zhou X.
        • Ran L.
        • Yang J.
        • et al.
        Resveratrol attenuates trimethylamine-N-Oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota.
        MBio. 2016; 7: e02210-e02215
        • Thaiss C.A.
        • Levy M.
        • Korem T.
        • Dohnalová L.
        • Shapiro H.
        • Jaitin D.A.
        • et al.
        Microbiota diurnal rhythmicity programs host transcriptome oscillations.
        Cell. 2016; 167: 1495-1510
        • Win S.
        • Than T.A.
        • Han D.
        • Petrovic L.M.
        • Kaplowitz N.
        C-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice.
        J Biol Chem. 2011; 286: 35071-35078
        • Sharma M.
        • Gadang V.
        • Jaeschke A.
        Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.
        Mol Pharmacol. 2012; 82: 1001-1007
        • Nakagawa H.
        • Maeda S.
        • Hikiba Y.
        • Ohmae T.
        • Shibata W.
        • Yanai A.
        • et al.
        Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.
        Gastroenterology. 2008; 135: 1311-1321
        • Hanawa N.
        • Shinohara M.
        • Saberi B.
        • Gaarde W.A.
        • Han D.
        • Kaplowitz N.
        Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury.
        J Biol Chem. 2008; 283: 13565-13577
        • Kon K.
        • Kim J.S.
        • Jaeschke H.
        • Lemasters J.J.
        Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.
        Hepatology. 2004; 40: 1170-1179
        • Saito C.
        • Lemasters J.J.
        • Jaeschke H.
        C-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.
        Toxicol Appl Pharmacol. 2010; 246: 8-17
        • Han D.
        • Dara L.
        • Win S.
        • Than T.A.
        • Yuan L.
        • Abbasi S.Q.
        • et al.
        Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.
        Trends Pharmacol Sci. 2013; 34: 243-253